New Ray Medicine International Holding Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was HKD 133.214 million compared to HKD 118.632 million a year ago. Net loss was HKD 69.731 million compared to HKD 44.109 million a year ago. Basic loss per share from continuing operations was HKD 0.0417 compared to HKD 0.0264 a year ago.